Nusinersen Sodium (12㎎/5mL/1vial) 2 vials,and 10 other contracts<br />

2026-11-03

Official in charge of disbursement of the procuring entity : Hiroshi Maruyama, The Obligating Officer Administration Bureau, Chiba University Classification of the products to be procured : Nature and quantity of the products to be purchased : A Nusinersen Sodium (12㎎/5mL/1vial) vials B Onasemnogene abeparvove Set C Human (allogeneic) mesenchymal stem cells derived from bone marrow (10.8ml/1bag) 7 bags D Tisagenlecleucel Set E Lisocabtagene maraleucel 1 Set F Idecabtagene vicleucel 1 Set G Axicabtagene Ciloleucel Set H Ravulizumab (Genetical Recombination) (300㎎/3mL/1vial) 1,29 vials I Ravulizumab (Genetical Recombination) (1100㎎/11mL/1vial) 23 vials J Inebilizumab (Genetical Recombination) (100㎎/10mL/1vial, 3vials/ 1case) 1 cases K Satralizumab (Genetical Recombination) (120㎎/1mL/1syringe) 7 syringes Delivery period : From April, 202 through 3 March, 202 Delivery place : Chiba University Hospital Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall : A not come under Article and of the Regulation concerning the Contract for Chiba University, Furthermore, minors, Person under Conservatorshi or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause, B have the Grade A or Grade B qualification during fiscal 202 in the Kanto・Koshinetsu area in sales of product for participating in tenders by Single qualification for every ministry and agency, or in tenders by National University Corporation, C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices, D prove to have the ability to deliver the products, required by this notice, on the date and to the place specified by the Obligating Officer, E meet the qualification requirements which The Obligating Officer, Administration Bureau, may specify in accordance with Article of the Regulation, F not be currently under a suspension of business order as instructed by The Obligating Officer. Time limit of tender : 1 : 00, 2 March, 202 Contact point for the notice : Takuya Hashimoto, Procurement Group, Management Division, Chiba University Hospital, 1-8- Inohana Chuo-ku Chiba-shi 260-867 Japan, TEL 043-226-268 ⑼ Please be noted that if it is indicated that environmental conditions relating to the procurement are laid down in its tender documents.

Japan

2026-03-26